Accessories Segment to Register Highest CAGR During 2021–2028
According to our latest study on “Autotransfusion Devices Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Type, Application, and End-User,” and in the global autotransfusion devices market size is expected to grow from US$ 1,000.26 million in 2021 to US$ 1,331.99 million by 2028; it is estimated to grow at a CAGR of 4.2% from 2021 to 2028. The report highlights the key factors driving the autotransfusion devices market growth and prominent players with their developments in the market.
Based on type, the market is segmented into products and accessories. In 2021, accessories segment held the largest share due to rising demand for technologically advanced products in developed and developing economies including the US, Germany, U.K., France, Japan, and others. Moreover, the rising need of autotransfusion to treat chronic diseases such as cardiovascular diseases, cancer, and traumas is likely to drive the market growth in the forecast period. Moreover, the same segment has the highest CAGR in the anticipated period.
The autotransfusion devices market, by application, is segmented into cardiac surgeries, orthopedic surgeries, organ transplantation, trauma procedures, and others. The cardiac surgeries segment held the largest share of the market in 2021, while the organ transplantation segment is also estimated to register the highest CAGR in the market during the forecast period.
By end-user, the autotransfusion devices market is segmented into hospitals, specialty clinics, and ambulatory surgical centers. The hospitals segment held largest share of the market in 2021, likely to continue its dominance in the market during the forecast period. However, the ambulatory surgical centers segment is anticipated to register the highest CAGR in the autotransfusion devices market during the forecast period.
The recent outbreak of recent COVID-19 variants in the region further restricts the surgical procedures performed, increasing the burden of infected countries. However, the healthcare facilities are handling the situation and providing more innovative solutions for delivering healthcare. Moreover, the healthcare system has again took running pace nowadays. The postponed surgical procedures that are now taking place, posing high demand of autotransfusion devices and has opened the opportunity to gain the market share with innovative products. For Instance, according to American Association of Orthopaedic Surgeons and Agency for Healthcare Research and Quality (AHRQ), an estimated 700,000 knee replacement and around 450,000 hip replacement procedures are performed in U.S. each year. Besides, according to an article published by University of Alabama in 2021, it was reported that 320,000 coronary artery bypass grafting procedures were performed in U.S. in 2020. Thus, the overall COVID-19 impact on market is negative but the market is again gaining traction and expected to grow in coming years.
Autotransfusion Devices Market: Competition Landscape and Key Developments
The autotransfusion devices market majorly consists of the players such as BD, Braile Biomedica, Fresenius SE & Co. KGaA, Haemonetics Corporation, LivaNova PLC, Medtronic, Redax S.p.A., SARSTEDT AG and Co. KG, Teleflex Incorporated and Zimmer Biomet among others are among the leading companies operating in the market.
Autotransfusion Devices Market, by region, 2021 (%)
Autotransfusion Devices Market Size, Share | Analysis - 2028
Download Free Sample
Autotransfusion Devices Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Product and Accessories); Application (Cardiac Surgeries, Orthopedic Surgeries, Organ Transplantation, Trauma Procedures, and Others); End User (Hospitals, Specialty Clinics, and Ambulatory Surgery Centers)
The autotransfusion devices market has been geographically segmented as follows:
Autotransfusion Devices Market Size, Share | Analysis - 2028
Download Free SampleAutotransfusion Devices Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Product and Accessories); Application (Cardiac Surgeries, Orthopedic Surgeries, Organ Transplantation, Trauma Procedures, and Others); End User (Hospitals, Specialty Clinics, and Ambulatory Surgery Centers)
Based on geography, the market is segmented into North America, Europe, Asia Pacific (APAC), Middle East & Africa (MEA), and South & Central America (SCAM). The North America is sub-segmented into the US, Canada, and Mexico. Europe is further segmented into France, Germany, the UK, Spain, Italy, and the Rest of Europe. Asia Pacific (APAC) is further segmented into China, India, Japan, Australia, South Korea, and the Rest of Asia Pacific. Middle East & Africa (MEA) is segmented Into Saudi Arabia, the UAE, South Africa, and the Rest of Middle East & Africa. The South and Central America (SCAM) is sub-segmented into Brazil, Argentina, and the Rest of South and Central America.
Contact Us